Support our Foundation of Myology project
Webinar organised by EURO-NMD in collaboration with ERN-RND and EAN. Thursday 27 mai 2021 – 4:00 am (Paris time) What’s new in FSHD ? Prof. Sabrina Sacconi (CHU Nice, France) Dr Teresinha Evangelista (Association Institut de Myologie…
The Institute of Myology Located in Paris at the heart of Europe’s largest hospital, the Pitié-Salpêtrière, the Institute of Myology was created in 1996 under the impetus of an association of patients and parents of patients, the AFM- Telethon. Its…
The French-Iranian symposium, supported by FILNEMUS (the French Rare Health Care for Neuromuscular Diseases Network), will take place by videoconference on Friday, May 21st, 2021, at 12h30 (Paris time). It will focus on therapeutic updates in Neuromuscular Disorders. Speakers :…
The European Neuromuscular Centre (ENMC) is launching a mentoring programme this year aimed at mid-career neuromuscular disease specialists. This programme is open to doctors and scientists, as well as to individuals who wish to deliver innovation and federative and co-operative…
A research associate and an engineer positions are available in the BOND group, at the Myology Center for Research, Sorbonne University, INSERM U974, Institute of Myology (Pitié-Salpêtrière hospital, Paris). Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized by the…
Functional scales are very useful in neuromuscular diseases (NMD), for monitoring NMD patients as well as in therapeutic trials where they can be used as outcome measures. They can be generic, such as the measurement of motor function (MFM), or…
A first patient with Duchenne muscular dystrophy has received a gene therapy treatment at I-Motion, the paediatric clinical platform for neuromuscular diseases, in the context of a clinical trial conducted by Généthon. A first decisive step! A young boy with…
Interview with Stéphane Vassilopoulos, researcher at the Muscle Organization & Therapy of Dominant Centronuclear Myopathy laboratory in Team 2 at the Institute of Myology Research Centre, headed by Marc Bitoun. He and his group are interested in the muscle cell…
The primary endpoint of the second part of the FIREFISH clinical trial has been met. This is an announcement by Roche and PTC Therapeutics, the two laboratories that develop risdiplam, a small molecule orally administered correcting the maturation of SMN2.…
The Institute of Myology wishes you all the best for 2020 Welcome to the first issue of our newsletter for the new year! The counter of the 2019 Telethon, which took place on December 6 and 7, displays…